NCT01756014

Brief Summary

The investigators will evaluate the determinants of cerebral impairment in patients with non-ischemic heart failure compared to controls, and its relation to cognitive function. They hypothesize that patients with heart failure have impaired brain perfusion and hemodynamic factors are associated with cognitive dysfunction.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

December 19, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 24, 2012

Completed
Last Updated

December 24, 2012

Status Verified

December 1, 2012

Enrollment Period

11 months

First QC Date

December 19, 2012

Last Update Submit

December 21, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Determinants of cerebral impairment

    Determinants of cerebral impairment in patients with heart failure compared to controls, where cerebral impairment is defined as decreased cognitive function and cerebral hypoperfusion

    Baseline

Secondary Outcomes (7)

  • Prevalence of cognitive impairment

    Baseline

  • Relation of cognitive impairment with local perfusion

    Baseline

  • Relation of cognitive impairment with the severity of heart failure

    Baseline

  • Relation of cognitive impairment with cardiac output

    Baseline

  • Relation of cognitive impairment with the severity of congestion

    Baseline

  • +2 more secondary outcomes

Study Arms (3)

Controls

Age matched healthy subjects

Mild DCM

Heart failure patients with dilated cardiomyopathy (DCM) with NYHA-functional class II

Severe DCM

Heart failure patients with dilated cardiomyopathy (DCM) with NYHA-functional class III/IV

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

* Patients with heart failure due to dilated cardiomyopathy with NYHA II or NYHA II/IV. * Healthy patients

You may qualify if:

  • Healthy subject, as assessed by clinician
  • Age matched with patient group

You may not qualify if:

  • Age \< 18 years
  • Carotid artery or intracranial disease, as assessed by echo-doppler (significant stenosis \> 50%)
  • Unable or unwilling to undergo MRI
  • The presence of ferromagnetic material in or on the body, for example tattoos with ferrous ink or pacemakers or cardiac defibrillators. Also the presence of pregnancy and claustrophobia.
  • History of cognitive impairment
  • Unable to understand procedures
  • Unable or unwilling to provide informed consent
  • Heart failure due to DCM
  • patients with NYHA class II
  • patients with NYHA class III/IV
  • Age \< 18 years
  • History of myocardial infarction
  • History of peripheral artery disease
  • History of cerebrovascular disease or
  • Carotid artery or intracranial disease, as assessed by echo-doppler (significant stenosis \> 50%)
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Centre Groningen

Groningen, Provincie Groningen, 9700 RB, Netherlands

RECRUITING

Related Publications (1)

  • Erkelens CD, van der Wal HH, de Jong BM, Elting JW, Renken R, Gerritsen M, van Laar PJ, van Deursen VM, van der Meer P, van Veldhuisen DJ, Voors AA, Luijckx GJ. Dynamics of cerebral blood flow in patients with mild non-ischaemic heart failure. Eur J Heart Fail. 2017 Feb;19(2):261-268. doi: 10.1002/ejhf.660. Epub 2016 Nov 14.

MeSH Terms

Conditions

Heart FailureCardiomyopathy, DilatedCognitive Dysfunction

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesCardiomegalyCardiomyopathiesLaminopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCognition DisordersNeurocognitive DisordersMental Disorders

Central Study Contacts

Adriaan A Voors, MD/PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. dr.

Study Record Dates

First Submitted

December 19, 2012

First Posted

December 24, 2012

Study Start

January 1, 2012

Primary Completion

December 1, 2012

Last Updated

December 24, 2012

Record last verified: 2012-12

Locations